Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTG Centogene > Detailed Quotes

CNTG Centogene

1.250
-0.040-3.10%
Close 09/27 16:00 ET
High
1.260
Open
1.230
Turnover
11.93K
Low
1.220
Pre Close
1.290
Volume
9.64K
Market Cap
33.85M
P/E(TTM)
Loss
52wk High
10.755
Shares
27.08M
P/E(Static)
Loss
52wk Low
1.190
Float Cap
7.86M
Bid/Ask %
11.11%
Historical High
28.711
Shs Float
6.29M
Volume Ratio
1.16
Historical Low
1.190
Dividend TTM
--
Div Yield TTM
--
P/B
0.98
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
3.10%
Avg Price
1.237
Lot Size
1
Float Cap
7.86M
Bid/Ask %
11.11%
Historical High
28.711
Shs Float
6.29M
Volume Ratio
1.16
Historical Low
1.190
Dividend TTM
--
P/B
0.98
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
3.10%
Avg Price
1.237
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
CEO: Ms. Kim Stratton
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...